
Circulating autoantibodies against the NR2 peptide of the NMDA receptor are associated with subclinical brain damage in hypertensive patients with other pre-existing conditions for vascular risk
Keywords: آتروفی مغزی; NR2 antibodies; Hypertension; Subclinical brain damage, vascular pre-existing conditions; White matter hyperintensities; Brain atrophy; HT; arterial hypertension; PEC; vascular pre-existing conditions; SLI; silent lacunar infarcts; WMH; white matter hyper